Phytocannabinoids for Neurocognitive Disorders

Résumé fourni par la source

Neurocognitive disorders (NCDs) are characterized by cognitive decline that is caused by underlying brain pathologies, such as Alzheimer&s;s disease, traumatic brain injury, and neurovascular injury. There is a dearth of therapeutic options for people with a NCD to manage cognitive symptoms and mitigate underlying brain pathologies, with new strategies urgently required. Cannabinoids, such as cannabidiol and low-dose Δ-9-tetrahydrocannabinol, have been shown to improve cognitive function in animal models, while acting on a range of common mechanisms across NCDs, such as neuroinflammation and oxidative stress. This chapter provides an overview of cannabinoids with potential therapeutic properties for the treatment of cognitive decline in NCDs.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.